Brief: Altamira Therapeutics Regains Listing Compliance With Nasdaq Minimum Bid Requirement
09/11/2022 15:49
Nov 9 (Reuters) - Altamira Therapeutics Ltd CYTO.O :
* ALTAMIRA THERAPEUTICS REGAINS LISTING COMPLIANCE WITH
NASDAQ
MINIMUM BID REQUIREMENT
Source text for Eikon: ID:nGNX5CPRm7
Further company coverage: CYTO.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Altamira Therapeutics
See all newsBrief: Altamira Therapeutics Reports Full Year 2024 Results
Brief: Altamira Therapeutics Announces Transition From Nasdaq To OTC Markets
Brief: Altamira Therapeutics Provides Update On Nasdaq Listing
Brief: Altamira Therapeutics Provides Business Update And First Half 2024 Financial Results
Brief: Altamira Therapeutics Announces Pricing Of Up To $12.0 Mln Public Offering